Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

4.5

Margin Of Safety %

-27

Put/Call OI Ratio

0.6

EPS Next Q Diff

0.11

EPS Last/This Y

3.41

EPS This/Next Y

1.28

Price

359.21

Target Price

361.07

Analyst Recom

2.7

Performance Q

42.55

Relative Volume

1.29

Beta

0.81

Ticker: PEN




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2025-12-26PEN316.990.310.232195
2025-12-29PEN314.910.304.332237
2025-12-30PEN314.480.310.002251
2025-12-31PEN311.030.290.062356
2026-01-02PEN309.450.296.652399
2026-01-05PEN315.190.410.042665
2026-01-06PEN316.970.400.032741
2026-01-07PEN316.280.390.022809
2026-01-08PEN315.390.351.003009
2026-01-09PEN322.560.360.013015
2026-01-12PEN319.610.300.033466
2026-01-13PEN301.210.270.053756
2026-01-14PEN313.30.180.295637
2026-01-15PEN350.490.240.536176
2026-01-16PEN350.880.400.127176
2026-01-20PEN355.320.550.543592
2026-01-21PEN357.420.562.323660
2026-01-22PEN358.40.581.313786
2026-01-23PEN358.810.602.583850
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-12-26PEN317.2012.956.53.77
2025-12-29PEN315.0312.953.93.77
2025-12-30PEN314.3612.955.03.77
2025-12-31PEN310.9412.952.83.77
2026-01-02PEN309.4512.954.33.77
2026-01-05PEN315.1112.960.03.77
2026-01-06PEN316.9812.957.03.77
2026-01-07PEN316.2012.954.93.77
2026-01-08PEN315.8812.955.23.77
2026-01-09PEN322.1012.960.63.77
2026-01-12PEN319.7212.853.43.77
2026-01-13PEN301.1112.841.23.77
2026-01-14PEN313.4012.865.73.77
2026-01-15PEN350.4212.884.73.77
2026-01-16PEN350.7812.855.63.77
2026-01-20PEN355.3714.058.73.77
2026-01-21PEN357.8114.057.13.77
2026-01-22PEN358.4814.756.03.77
2026-01-23PEN359.2114.755.93.77
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-12-26PEN-10.842.544.24
2025-12-29PEN-9.782.544.24
2025-12-30PEN-9.782.544.24
2025-12-31PEN-9.782.544.24
2026-01-02PEN-9.782.544.24
2026-01-05PEN-9.742.754.24
2026-01-06PEN-9.742.754.24
2026-01-07PEN-9.752.754.24
2026-01-08PEN-9.752.754.24
2026-01-09PEN-9.772.754.24
2026-01-12PEN-8.852.754.23
2026-01-13PEN-8.672.754.50
2026-01-14PEN-8.672.754.50
2026-01-15PEN-8.672.754.50
2026-01-16PEN-8.672.754.50
2026-01-20PEN-8.662.654.50
2026-01-21PEN-8.662.654.50
2026-01-22PEN-8.662.654.50
2026-01-23PEN-8.662.654.50
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

0.97

Avg. EPS Est. Current Quarter

1.09

Avg. EPS Est. Next Quarter

1.08

Insider Transactions

-8.66

Institutional Transactions

2.65

Beta

0.81

Average Sales Estimate Current Quarter

361

Average Sales Estimate Next Quarter

370

Fair Value

260.55

Quality Score

95

Growth Score

89

Sentiment Score

82

Actual DrawDown %

0.9

Max Drawdown 5-Year %

-62.6

Target Price

361.07

P/E

85.85

Forward P/E

71.08

PEG

1.67

P/S

10.57

P/B

10.35

P/Free Cash Flow

92.34

EPS

4.18

Average EPS Est. Cur. Y​

3.77

EPS Next Y. (Est.)

5.05

Target Price Estimates Raised

1

Target Price Estimates Lowered

Profit Margin

12.3

Relative Volume

1.29

Return on Equity vs Sector %

-15.2

Return on Equity vs Industry %

-5.2

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

55.9
Penumbra, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 4500
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, and aspiration pump under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as detachable coils to treat patients with a wide range of neurovascular lesions under the Penumbra SMART COIL and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
stock quote shares PEN – Penumbra, Inc. Stock Price stock today
news today PEN – Penumbra, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PEN – Penumbra, Inc. yahoo finance google finance
stock history PEN – Penumbra, Inc. invest stock market
stock prices PEN premarket after hours
ticker PEN fair value insiders trading